882855-71-2 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 4,4-difluorocyclohexanecarboxylate is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure, including the cyclohexane ring and the two fluoride atoms, allows for the creation of new molecules with potential therapeutic applications.
Used in Agrochemical Industry:
Methyl 4,4-difluorocyclohexanecarboxylate is used as a chemical intermediate in the production of agrochemicals. Its involvement in chemical reactions can lead to the development of new compounds with pesticidal or herbicidal properties, contributing to more effective crop protection strategies.
Used in Organic Synthesis:
Methyl 4,4-difluorocyclohexanecarboxylate is used as a key component in organic synthesis processes. Its reactivity and structural features make it a valuable building block for the creation of a wide range of organic compounds, which can be further utilized in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 882855-71-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,8,5 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 882855-71:
(8*8)+(7*8)+(6*2)+(5*8)+(4*5)+(3*5)+(2*7)+(1*1)=222
222 % 10 = 2
So 882855-71-2 is a valid CAS Registry Number.
882855-71-2Relevant academic research and scientific papers
Pyrimidine amine compound, and preparation method and application thereof
-
, (2020/07/02)
The invention discloses a polycyclic compound, and a preparation method and an application thereof. The invention provides the polycyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof. The compound has a relatively good inhibition effect on CDK7.
Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase
Wang, Zhiyong,Silverman, Richard B.
, p. 2242 - 2252 (2007/10/03)
Inhibition of γ-aminobutyric acid aminotransferase (GABA-AT) could raise the concentration of GABA, an inhibitory neurotransmitter in the human brain, and could have therapeutic applications for a variety of neurological diseases including epilepsy. Four fluorine-containing analogues of GABA with conformations restricted by a cyclohexane ring system were designed and synthesized, but unlike some of their five-membered ring counterparts, minimal inhibition of GABA-AT was observed. It is likely that the rigid chair conformation of these compounds cannot be accommodated well in the enzyme's active site.
